Validación de la versión española de los cuestionarios “Movement Imagery Questionnaire-Revised Second Edition” (MIQ-RS) y “Kinesthetic and Visual Imagery Questionnaire” (KVIQ) en personas con Enfermedad de Parkinson

  1. Moreno Verdú, Marcos
Supervised by:
  1. Patricia Martín Casas Director
  2. María de los Angeles Atín Arratibel Director

Defence university: Universidad Complutense de Madrid

Fecha de defensa: 10 June 2021

  1. Susana Muñoz Lasa Chair
  2. Ibai Lopez de Uralde Villanueva Secretary
  3. Cecilia Estrada Barranco Committee member
  4. Roberto Cano de la Cuerda Committee member
  5. Francisco Molina Rueda Committee member
  1. Radiología, Rehabilitación y Fisioterapia

Type: Thesis


Parkinson’s Disease (PD) is a common neurodegenerative pathology characterized by its markedly heterogeneous motor and nonmotor symptoms and its chronic and progressive clinical course. People with PD exhibit motor control disturbances, although maintain their learning ability.Motor Imagery (MI) is the mental rehearsal of a movement without a physical motor execution. It is an active cognitive process during which motor action is internally represented through working memory. It can be used as a motor learning technique due to it shares brain loci with physical motor execution. Its clinical use is being assessed in people with PD, and the person’s MI ability has been described as a factor of MI training effectiveness. MI ability can be evaluated with direct and indirect methods. Regarding indirect methods, psychometric questionnaires are focused on quantifying the intensity with which the subject perceives MI (i.e., vividness), with a clear differentiation between sensory modalities (visual or kinesthetic). One of the most frequently used questionnaires are the Movement Imagery Questionnaire-Revised Second Edition (MIQ-RS) and the Kinesthetic and Visual Imagery Questionnaire (KVIQ). The KVIQ has three versions depending on the number of items used during the assessment (34 if bilaterally assessed, 20 if unilaterally or 10 if the short version is administered). These instruments have proved their biological validity in healthy people, but their use in people with PD must be ascertained in terms of validity and reliability...